华兰疫苗(301207.SZ)：前三季度净利润1.32亿元 同比减少50.51%

Core Viewpoint - Hualan Vaccine (301207.SZ) reported a significant decline in revenue and net profit for the first three quarters of 2025 compared to the previous year [1] Financial Performance - The company achieved an operating income of 806 million yuan, representing a year-on-year decrease of 15.81% [1] - The net profit attributable to shareholders was 132 million yuan, down 50.51% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 86.26 million yuan, a decrease of 56.02% year-on-year [1] - Basic earnings per share were reported at 0.2224 yuan [1]